Search research articles
Contact Us
Filters
Showing results (731-740 of 792) with videos related to
Page
of 80
Sort By:
The Journal of Allergy and Clinical Immunology
|
September 28, 2016
Early-onset pediatric atopic dermatitis is T<sub>H</sub>2 but also T<sub>H</sub>17 polarized in skin
Hitokazu Esaki, Patrick M Brunner, Yael Renert-Yuval, et al.
Molecular Neurodegeneration
|
October 15, 2025
Modeling neurodegeneration in the retina and strategies for developing pan-neurodegenerative therapies
Emily L Ward, Larry Benowitz, Thomas M Brunner, et al.
Blood Cancer Journal
|
November 1, 2024
Venous thromboembolism in adolescents and young adults with acute lymphoblastic leukemia treated on a pediatric-inspired regimen
Shai Shimony, Hari S Raman, Yael Flamand, et al.
Blood Advances
|
June 30, 2026
A Phase Ib/II study of ceralasertib, a selective inhibitor of ATR, in patients with relapsed or refractory MDS and CMML
Andrew M Brunner, Yiwen Liu, Jacqueline S Garcia, et al.
British Journal of Haematology
|
July 20, 2016
Haematopoietic cell transplantation with and without sorafenib maintenance for patients with FLT3-ITD acute myeloid leukaemia in first complete remission
Andrew M Brunner, Shuli Li, Amir T Fathi, et al.
Leukemia
|
January 3, 2022
Marrow ring sideroblasts are highly predictive for TP53 mutation in MDS with excess blasts
David M Swoboda, Rashmi Kanagal-Shamanna, Andrew M Brunner, et al.
Blood Advances
|
September 23, 2022
Enasidenib as maintenance following allogeneic hematopoietic cell transplantation for IDH2-mutated myeloid malignancies
Amir T Fathi, Haesook T Kim, Robert J Soiffer, et al.
JAMA Oncology
|
December 17, 2020
Effectiveness of Integrated Palliative and Oncology Care for Patients With Acute Myeloid Leukemia: A Randomized Clinical Trial
Areej El-Jawahri, Thomas W LeBlanc, Alison Kavanaugh, et al.
British Journal of Haematology
|
July 13, 2026
Clinical outcomes of combination treatment with FMS-like tyrosine kinase 3 (FLT3) and isocitrate dehydrogenase 1/2 (IDH1/2) inhibitors in patients with acute myeloid leukaemia
Catherine Gutierrez Moore, Donian I Chyong, Naval Daver, et al.
Haematologica
|
August 5, 2021
Characteristics and outcome of patients with core-binding factor acute myeloid leukemia and FLT3-ITD: results from an international collaborative study
Sabine Kayser, Michael Kramer, David Martínez-Cuadrón, et al.
Page
of 80
Search research articles
Search
Showing results (731-740 of 792) with videos related to
Sort By:
Page
of 80
The Journal of Allergy and Clinical Immunology
|
September 28, 2016
Early-onset pediatric atopic dermatitis is T<sub>H</sub>2 but also T<sub>H</sub>17 polarized in skin
Hitokazu Esaki, Patrick M Brunner, Yael Renert-Yuval, et al.
Molecular Neurodegeneration
|
October 15, 2025
Modeling neurodegeneration in the retina and strategies for developing pan-neurodegenerative therapies
Emily L Ward, Larry Benowitz, Thomas M Brunner, et al.
Blood Cancer Journal
|
November 1, 2024
Venous thromboembolism in adolescents and young adults with acute lymphoblastic leukemia treated on a pediatric-inspired regimen
Shai Shimony, Hari S Raman, Yael Flamand, et al.
Blood Advances
|
June 30, 2026
A Phase Ib/II study of ceralasertib, a selective inhibitor of ATR, in patients with relapsed or refractory MDS and CMML
Andrew M Brunner, Yiwen Liu, Jacqueline S Garcia, et al.
British Journal of Haematology
|
July 20, 2016
Haematopoietic cell transplantation with and without sorafenib maintenance for patients with FLT3-ITD acute myeloid leukaemia in first complete remission
Andrew M Brunner, Shuli Li, Amir T Fathi, et al.
Leukemia
|
January 3, 2022
Marrow ring sideroblasts are highly predictive for TP53 mutation in MDS with excess blasts
David M Swoboda, Rashmi Kanagal-Shamanna, Andrew M Brunner, et al.
Blood Advances
|
September 23, 2022
Enasidenib as maintenance following allogeneic hematopoietic cell transplantation for IDH2-mutated myeloid malignancies
Amir T Fathi, Haesook T Kim, Robert J Soiffer, et al.
JAMA Oncology
|
December 17, 2020
Effectiveness of Integrated Palliative and Oncology Care for Patients With Acute Myeloid Leukemia: A Randomized Clinical Trial
Areej El-Jawahri, Thomas W LeBlanc, Alison Kavanaugh, et al.
British Journal of Haematology
|
July 13, 2026
Clinical outcomes of combination treatment with FMS-like tyrosine kinase 3 (FLT3) and isocitrate dehydrogenase 1/2 (IDH1/2) inhibitors in patients with acute myeloid leukaemia
Catherine Gutierrez Moore, Donian I Chyong, Naval Daver, et al.
Haematologica
|
August 5, 2021
Characteristics and outcome of patients with core-binding factor acute myeloid leukemia and FLT3-ITD: results from an international collaborative study
Sabine Kayser, Michael Kramer, David Martínez-Cuadrón, et al.
Page
of 80